IPERTROFAN

This brand name is authorized in Lithuania, Poland, Romania.

Active ingredients

The drug IPERTROFAN contains one active pharmaceutical ingredient (API):

1
UNII B7FBW3Y74G - MEPARTRICIN
 
Read more about Mepartricin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G04CX03 Mepartricin G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CX Other drugs used in benign prostatic hypertrophy
Discover more medicines within G04CX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
LT Valstybinė vaistų kontrolės tarnyba 1010062, 1010378, 1066904, 1078157
PL Rejestru Produktów Leczniczych 100079406
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W04114002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈